Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a setting of chemotherapy treatment: An assessment of FDA MedWatch database.
V. Garg
No relevant relationships to disclose
Y. Balagula
No relevant relationships to disclose
D. W. Raisch
Research Funding - Abraxis BioScience
M. J. Anadkat
Consultant or Advisory Role - Bristol-Myers Squibb; ImClone Systems
Honoraria - Bristol-Myers Squibb; Eisai
M. E. Lacouture
Consultant or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Genzyme; GlaxoSmithKline; Hana BioSciences; ImClone Systems; Lilly; Onyx; OSI Pharmaceuticals; Pfizer; Roche; Wyeth
Honoraria - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genetic Technologies; Genzyme; GlaxoSmithKline; Hana BioSciences; ImClone Systems; Lilly; Onyx; OSI Pharmaceuticals; Pfizer; Roche; Wyeth
Research Funding - Hana BioSciences; Onyx